Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Tetracycline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 4 Gastritis 4 Peptic Ulcer 3 Lymphoma, B-Cell, Marginal Zone 3 Dyspepsia 3 Lymphoma 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Stomach Ulcer 1 Rosacea 1 Meibomian Gland Dysfunction 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1 Dysbiosis 1 Chalazion 1 Breast Neoplasms 1 Ameloblastoma 1

Interventions

Rituximab 305 Cyclophosphamide 287 Etoposide 125 fludarabine phosphate 124 Peripheral Blood Stem Cell Transplantation 107 fludarabine 104 Filgrastim 103 Melphalan 91 Mycophenolic Acid 87 Whole-Body Irradiation 80 Vincristine 80 Cytarabine 77 Busulfan 77 Doxorubicin 71 Radiotherapy 70 Prednisone 67 Cyclosporine 67 Tacrolimus 64 Bendamustine Hydrochloride 61 Methotrexate 56 Granulocyte Colony-Stimulating Factor 56 Antilymphocyte Serum 50 Carmustine 48 Dexamethasone 44 Gemcitabine 42 Lenalidomide 41 venetoclax 39 Bortezomib 35 obinutuzumab 33 ibritumomab tiuxetan 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01010295 2013-11-25

IELSG27

International Extranodal Lymphoma Study Group (IELSG)

Phase 2 Completed

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡